1
/
of
0
FDA Drug Approval, N217569, VASOPRESSIN IN SODIUM CHLORIDE 0.9%
FDA Drug Approval, N217569, VASOPRESSIN IN SODIUM CHLORIDE 0.9%
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 217569
Company: BAXTER HLTHCARE CORP
Drug Name: VASOPRESSIN IN SODIUM CHLORIDE 0.9%
Active Ingredients: VASOPRESSIN
Strength: 40UNITS/100ML (0.4UNITS/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 09/29/2023
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: BAXTER HLTHCARE CORP
Drug Name: VASOPRESSIN IN SODIUM CHLORIDE 0.9%
Active Ingredients: VASOPRESSIN
Strength: 40UNITS/100ML (0.4UNITS/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 09/29/2023
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details